CIGA Healthcare

Last updated

CIGA Healthcare is a British manufacturer of lateral flow assay diagnostic tests. [1] It is under contract to the British government for the supply of AbC-19 rapid antibody tests, [2] a test for the presence of IgG antibody against the SARS-CoV-2 spike protein, [3] as part of the UK Rapid Test Consortium program. [4]

Contents

Distribution

CIGA Healthcare will be responsible[ when? ] for assembly and distribution of the AbC-19 rapid antibody tests, and has also been awarded distribution in the US after recent FDA approval. [5]

References

  1. ↑ "Abingdon Health announces its latest expansion and additional manufacturing capacity". Lifescience Industry News. 18 June 2020. Retrieved 12 November 2020.[ permanent dead link ]
  2. ↑ "Government invests in UK-developed antibody tests from UK Rapid Test Consortium". GOV.UK. Retrieved 12 November 2020.
  3. ↑ Gill, Dipender; Ponsford, Mark J. (11 November 2020). "Testing for antibodies to SARS-CoV-2". BMJ. 371 m4288. doi: 10.1136/bmj.m4288 . ISSN   1756-1833. PMID   33315587.
  4. ↑ Symon, Ken (19 October 2020). "Medical diagnostics company signs deal on delivery of Covid-19 tests". businessInsider. Retrieved 12 November 2020.
  5. ↑ "Yorkshire developed Covid-19 test approved for use in North America | TheBusinessDesk.com". Yorkshire. 17 November 2020. Retrieved 13 April 2021.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.